Showing 1401-1410 of 2526 results for "".
- Study Uncovers Novel Synaptic Intricacies Inside the Retinahttps://modernod.com/news/study-uncovers-novel-synaptic-intricacies-inside-the-retina/2481687/A Northwestern Medicine study has uncovered novel cellular mechanisms within the retina, findings that researchers say could help advance the development of targeted therapeutics for diseases and conditions impacting vision. The findings were
- Zeiss Unveils Disposable Warm Eye Maskshttps://modernod.com/news/zeiss-unveils-disposable-zeiss-warm-eye-masks/2481674/Zeiss announced the release of Zeiss Warm Eye Masks, individually wrapped and disposable masks designed to refresh and soothe dry, tired eyes. The masks use gentle heat to soothe, relax and stimulate the oil glands (meibomian glands) in eyelids. The warmth helps to unbloc
- Julie Schornack, OD, Named First Female President of Marshall B. Ketchum Universityhttps://modernod.com/news/julie-schornack-od-named-first-female-president-of-marshall-b-ketchum-university/2481585/Marshall B. Ketchum University (MBKU), an independent, private, non-profit, accredited educational institution in Fullerton, California has introduced Julie A. Schornack, OD, MEd, as its next president to lead the university. Dr. Schornack is the first female p
- Bausch + Lomb Reports More Than 65 Million Units of Contact Lens, Eye Care and Lens Care Materials Recycled Through Recycling Programshttps://modernod.com/news/bausch-lomb-reports-more-than-65-million-units-of-contact-lens-eye-care-and-lens-care-materials-recycled-through-one-by-one-and-biotrue-eye-care-recycling-programs/2481540/Bausch + Lomb announced its exclusive ONE by ONE and Biotrue Eye Care Recycling programs have recycled a total of 65.8 million units, or 397,194 pounds, of used contact lenses, eye care and lens care materials, which is equivalent to the weight of three commercial-sized airplanes.
- Oertli Instrumente Opens ‘Oertli Ophtha Lab’ at the Lucerne University of Applied Sciences and Artshttps://modernod.com/news/oertli-instrumente-opens-oertli-ophtha-lab-at-the-lucerne-university-of-applied-sciences-and-arts-1/2481489/Oertli Instrumente AG has created the ‘Oertli Ophtha Lab’ at the Lucerne University of Applied Sciences and Ar
- Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Spacehttps://modernod.com/news/celanese-announces-a-research-agreement-with-johns-hopkins-university-to-advance-sustained-ocular-drug-delivery-to-the-suprachoroidal-space/2481417/Specialty materials and chemical company Celanese announced an agreement with Johns Hopkins University Department of Ophthalmology to collaborate on a study of sustained drug delivery to the suprachoroidal space in the eye. A bioinert implant based on the Celanese's VitalD
- Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of DR, AMD, and Glaucomahttps://modernod.com/news/eyenuk-secures-the-first-european-union-mdr-certification-for-autonomous-ai-detection-of-diabetic-retinopathy-amd-and-glaucoma/2481377/Eyenuk has been approved to market its EyeArt AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage. The EyeArt AI system (version 3.0) has been granted a new European Commiss
- Elios Vision Announces Registration of Elios in the United Kingdomhttps://modernod.com/news/elios-vision-announces-registration-of-elios-in-the-united-kingdom/2481318/Elios, a technology used to treat glaucoma at the same time as cataract surgery, is now registered for use in the United Kingdom, according to Elios Vision. The Elios does not require an implant and is designed to provide long-lasting results that may free patients and th
- Opus Genetics Sponsors Uni-Rare Natural History Study for People with Inherited Retinal Diseaseshttps://modernod.com/news/opus-genetics-sponsors-uni-rare-natural-history-study-for-people-with-inherited-retinal-diseases/2481239/Opus Genetics announced the company will co-sponsor the Uni-Rare Study, a new natural history study for approximately 1,500 people with mutations in one of more than 300 rare genes associated with inherited retinal diseases (IRDs). The two-part Uni-Rare Study is being launched to charac
- Unity Biotechnology Announces Positive 24-Week Data from Phase 2 BEHOLD Study of UBX1325 in Patients with DMEhttps://modernod.com/news/unity-biotechnology-announces-positive-24-week-data-from-phase-2-behold-study-of-ubx1325-in-patients-with-dme/2481214/Unity Biotechnology announced that the key safety and efficacy endpoints were met at 24 weeks in the phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema (DME). The company intends to initiate a pivotal study in DME in the second half of 2023. At 24 weeks af